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Introduction 
The symptoms of oesophagogastric cancer are also found in benign conditions, making selection of primary care patients for referral and investigation problematic. We performed a systematic review of the risk of oesophagogastric cancer in dyspeptic patients from primary care and from referrals to open-access endoscopy clinics.
Research question
What is the diagnostic performance of patients’ symptoms associated with oesophagogastric cancers, presenting to primary care? 
Methods
We searched MEDLINE, EMBASE, Cochrane Library and CINAHL for studies of any design that included symptomatic adults in primary care or open access endoscopy clinics. Exclusions were studies of asymptomatic patients, screening, recurrent gastrointestinal cancers and secondary causes of upper GI symptoms. We extracted data from studies to estimate the diagnostic performance characteristics of features of upper GI cancer. Data were summarised in a meta-analysis. 
Results
We identified 14 studies. Oesophagogastric symptoms were grouped as: dyspepsia; anaemia; dysphagia; pain; reflux; nausea/vomiting/bloating; weight loss. Symptoms with the strongest summary sensitivity estimates were: pain 0.41 (0.24,0.62); dysphagia 0.40 (0.29,0.51); dyspepsia 0.37 (0.27,0.47). Summary positive likelihood ratios (LR+) were: pain 1.64 (1.20,2.24); dysphagia 11.92 (5.04,28.2); dyspepsia 0.94 (0.56,1.57). Corresponding diagnostic odds ratios (DOR) were: 2.09 (1.57,2.77); 19.1 (8.02,45.7); 0.91 (0.39-2.11) respectively. Sensitivity was lower for: anaemia 0.12 (0.08,0.19); nausea/vomiting/bloating 0.17 (0.06,0.39); reflux 0.24 (0.12,0.44); weight loss 0.25 (0.12,0.43). Corresponding LR+ and DOR values were: anaemia 4.32 (2.64,7.08) and 4.79 (2.92,7.85); nausea/vomiting/bloating 1.47 (0.57,3.79) and 1.57 (0.52,4.70); reflux 1.07 (0.58,1.99) and 1.10 (0.49,2.46); weight loss 5.46 (3.47,8.60) and 6.91 (4.95,9.65).
Conclusions
The risk of gastro-oesophageal cancers is highest with dysphagia, weight loss and anaemia, though the sensitivity of these symptoms was relatively low. The findings support the current policy of investigation of these symptoms, but also point to a population of low-risk but not no-risk patients currently not recommended for investigation.
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